Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor metadata or backend update with no visible changes to core content or user-facing features.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check35 days agoChange DetectedGlossary visibility was added and a revision tag shows v3.4.0 along with updated 'No FEAR Act Data' wording and a QC status entry. These changes are cosmetic and do not affect study content, eligibility criteria, or outcomes.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page header shows Revision: v3.3.4 and removes Revision: v3.3.3, a minor metadata update with no impact on study details or user workflow. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page footer was updated to Revision: v3.3.3 with the HHS Vulnerability Disclosure link removed and the previous Revision: v3.3.2 notice no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2. The previous Revision: v3.3.1 has been removed.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.